Analyst Articles
XORTX Update – Announces Results from COVID-19 Study and Receives Positive Feedback from FDA for XRx-101
XORTX is a biopharmaceutical company focused on developing drugs that could reduce serum acid uric levels. An Initiation Equity Research Report on XORTX was published by eResearch on August 16, 2020. [more]